Targeting HIV-1 with CRISPR/Cas9 delivered by retargeted adenoviruses effectively suppresses viral replication
S. Klinnert, P. C. Freitag, A. Plueckthun, K. J. Metzner
This study combines CRISPR/Cas9 with retargeted adenoviruses to suppress HIV-1 replication in primary CD4+ T cells.
bioRxiv · Dec 18, 2023 · PreprintMicrobiology